{"id":14437,"date":"2012-01-12T09:30:00","date_gmt":"2012-01-12T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/svizzera-cilag-saltano-120-posti-di-lavoro\/"},"modified":"2012-01-12T09:30:00","modified_gmt":"2012-01-12T08:30:00","slug":"svizzera-cilag-saltano-120-posti-di-lavoro","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/svizzera-cilag-saltano-120-posti-di-lavoro\/","title":{"rendered":"Swiss. Cilag: 120 jobs are lost"},"content":{"rendered":"

The government of the canton of Schaffhausen informed; Unia criticism<\/p>\n

<\/span><\/strong><\/p>\n

The pharmaceutical company Cilag, which specializes in injection and infusion solutions, plans to cut 120 of its 1,100 jobs in Schaffhausen. The subsidiary of the American giant Johnson & Johnson intends to drastically reduce the production of active ingredients from the end of 2015.<\/p>\n

<\/span><\/p>\n

The reasons for this "slimming cure"<\/span><\/strong><\/p>\n

The group motivates the restructuring plan with pressure on prices, particularly in the field of generic medicines. Manufacturing pharmaceutical substances for third parties has become less and less profitable in recent years, reads a release today. <\/p>\n

<\/span><\/p>\n

Informed government<\/span><\/strong><\/p>\n

<\/span><\/p>\n

The company hopes to be able to reduce headcount through natural fluctuations and transfers. According to the note, the cantonal government has been informed about the downsizing plans. The management promised a social plan.<\/p>\n

<\/span><\/p>\n

Union reaction<\/span><\/strong><\/p>\n

<\/span><\/p>\n

For its part, Unia has asked Cilag to waive the layoffs, also taking into account the good results obtained in 2010 by its parent company: in fact, profits grew by 10%. The union called the decision taken "incomprehensible and useless".<\/p>\n

<\/span><\/p>\n

Wednesday 11 January \u2013 RSI.ch<\/p>\n

<\/span><\/p>","protected":false},"excerpt":{"rendered":"

Il Governo del canton Sciaffusa informato; critica di Unia La società farmaceutica Cilag, specializzata nel campo delle soluzioni per iniezioni e infusioni, prevede di sopprimere a Sciaffusa 120 dei suoi 1’100 posti di lavoro. La filiale del gigante americano Johnson & Johnson intende ridurre drasticamente, da fine 2015, la produzione di principi attivi. Le motivazioni …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14437","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14437","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14437"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14437\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}